Package Insert: Information for the User
Exelon 4.6mg/24h Transdermal Patch
Exelon 9.5mg/24h Transdermal Patch
Exelon 13.3mg/24h Transdermal Patch
rivastigmina
Read this package insert carefully before starting to use this medication, as it contains important information for you.
1.What is Exelon and for what it is used
2.What you need to know before starting to use Exelon
3.How to use Exelon
4.Possible adverse effects
5.Storage of Exelon
6.Contents of the package and additional information
The active ingredient of Exelon is rivastigmine.
Rivastigmine belongs to the group of cholinesterase inhibitors. In patients with Alzheimer's disease, certain nerve cells die in the brain, resulting in low levels of acetylcholine neurotransmitters (a substance that allows nerve cells to communicate with each other). Rivastigmine acts by blocking the enzymes that break down acetylcholine: acetylcholinesterase and butyrylcholinesterase. By blocking these enzymes, Exelon allows an increase in acetylcholine in the brain, helping to reduce the symptoms of Alzheimer's disease.
Exelon is used for the treatment of adult patients with mild to moderately severe Alzheimer's disease, a progressive brain disorder that gradually affects memory, intellectual capacity, and behavior.
Do not use Exelon
If you find yourself in any of these situations, inform your doctor and do not use Exelon transdermal patches.
Warnings and precautions
Consult your doctor before starting to use Exelon:
If you find yourself in any of these situations, your doctor may consider the need for closer monitoring while you are being treated.
If you have not used the patches for more than three days, do not apply another one without consulting your doctor first.
Children and adolescents
Exelon should not be used in pediatric patients for the treatment of Alzheimer's disease.
Other medications and Exelon
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Exelon may interfere with anticholinergic medications, some of which are used to relieve stomach cramps or spasms (e.g. diciclomina), for the treatment of Parkinson's disease (e.g. amantadine), or to prevent motion sickness (e.g. difenhidramine, escopolamina, or meclizina).
Exelon transdermal patches should not be administered at the same time as metoclopramide (a medication used to relieve or prevent nausea and vomiting). Taking the two medications together may cause problems such as stiffness in the limbs and hand tremors.
If you need to undergo surgery while using Exelon transdermal patches, inform your doctor that you are using them, as they may excessively potentiate the effects of some anesthetic muscle relaxants.
Care should be taken when using Exelon transdermal patches with beta blockers (medications such as atenolol used to treat hypertension, angina, and other heart conditions). Taking the two medications together may cause complications such as a decrease in heart rate (bradycardia) that may lead to fainting or loss of consciousness.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using this medication.
If you are pregnant, it is necessary to evaluate the benefits of using Exelon against the possible adverse effects on the fetus. Exelon should not be used during pregnancy unless it is clearly necessary.
You should not breastfeed during your treatment with Exelon transdermal patches.
Driving and operating machinery
Your doctor will inform you if your condition allows you to drive or use machinery safely. Exelon transdermal patches may cause dizziness and severe confusion. If you feel dizzy or confused, do not drive, operate machinery, or perform other tasks that require your attention.
Follow exactly the administration instructions for Exelon transdermal patches as indicated by your doctor. If in doubt, consult your doctor, pharmacist, or nurse again.
IMPORTANT:
How to start treatment
Your doctor will indicate the most suitable dose of Exelon transdermal patch for your case.
Your doctor may adjust the dose during treatment depending on your individual needs.
If you have not used the patches for more than three days, do not put on a new one without consulting your doctor. Treatment with a transdermal patch can be restarted at the same dose if treatment is not interrupted for more than three days. Otherwise, your doctor will have you restart your treatment with Exelon 4.6mg/24h.
Exelon can be used with food, drink, and alcohol.
Where to place your Exelon transdermal patch
Every 24hours, remove the previous patch before putting on a new one in ONLY ONE of the possible areas. |
Each time you change the patch, remove the previous day's patch before putting on a new patch in a different area of the skin (for example, one day on the right side of the body and the next day on the left side; or one day on the upper part of the body and the next day on the lower part). Wait at least 14 days to put a new patch in the same area of the skin again.
Howto apply your Exelon transdermal patch
Exelon patches arethin, opaque plastic and stick to the skin. Each patch is in a protective envelope that protects it until you put it on. Do not open the envelope or remove the patch until you are ready to put it on.
|
-Each patch is in an individual protective envelope. Only open the envelope when you are ready to put on the patch. Cut the envelope along the dotted line with scissors and remove the patch from the envelope. |
-A protective sheet divided into two layers covers the adhesive side of the patch. Remove the first layer of the sheet without touching the adhesive side of the patch with your fingers. |
-Place the adhesive side of the patch on the upper or lower back or on the arm or chest (avoiding breasts in women) and then remove the second layer of the protective sheet. |
-Press firmly the patch against the skin with the palm of your hand for at least 30seconds and make sure the edges have stuck well. If this helps, you can write on the patch, for example, the day of the week, with a fine-tip pen. |
You must wear the patch continuously until you change it for a new one. When putting on a new patch, you can try different areas to find the ones that are most comfortable and where clothing does not rub against the patch.
How to remove your Exelon transdermal patch
Gently pull one of the edges of the patch to remove it slowly from the skin. If there are any remaining adhesive residues on the skin, soak the area with warm water and mild soap or use baby oil to remove it. Do not use alcohol or other solvents (nail polish removers or other solvents).
After removing the patch, wash your hands with soap and water. If you come into contact with your eyes or if your eyes become red after handling the patch, wash immediately with plenty of water and seek medical advice if the symptoms do not resolve.
Can you wear your Exelon transdermal patch when bathing, swimming, or exposing yourself to the sun?
What to do if a patch falls off
If a patch falls off, put on a new one for the rest of the day and change it the next day at the usual time.
When and for how long you should wear your Exelon transdermal patch
If you use more Exelon than you should
If you accidentally put on more than one patch, remove all the patches from the skin and inform your doctor. You may need medical attention. Some people who have taken accidentally high doses of Exelon orally have experienced nausea, vomiting, diarrhea, high blood pressure, and hallucinations.They may also experience bradycardia and dizziness.
If you forget to use Exelon
If you realize you have forgotten to put on a patch, put it on immediately. The next day, put on the next patch at the usual time. Do not put on two patches to compensate for the one you forgot.
If you interrupt treatment with Exelon
Inform your doctor or pharmacist if you stop using the patches.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, Exelon transdermal patches may cause side effects, although not everyone will experience them.
You may experience side effects more frequently when you start treatment or when your dose is increased. Side effects usually fade as your body gets used to the medicine.
If you notice any of the following serious side effects, remove the patch and inform your doctor immediately.
Frequent(may affect up to 1 in 10 people)
Poorly frequent(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect up to 1 in 10,000 people)
Unknown(cannot be estimated from available data)
If you notice any of the side effects listed above, remove the patch and inform your doctor immediately.
Other side effects experienced with Exelon capsules or oral solution and that may occur with patches:
Frequent(may affect up to 1 in 10 people)
Poorly frequent(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect up to 1 in 10,000 people)
Reporting side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this prospectus.You can also report them directly through the national notification system included in theAppendixV. By reporting side effects, you can contribute to providing more information about the safety of this medicine.
Exelon Composition
-The active ingredient is rivastigmine.
-Exelon 4.6mg/24h transdermal patch: Each patch releasing 4.6mg of rivastigmine in 24hours, measures 5cm2and contains 9mg of rivastigmine.
-Exelon 9.5mg/24h transdermal patch: Each patch releasing 9.5mg of rivastigmine in 24hours, measures 10cm2and contains 18mg of rivastigmine.
-Exelon 13.3mg/24h transdermal patch: Each patch releasing 13.3mg of rivastigmine in 24hours, measures 15cm2and contains 27mg of rivastigmine.
-The other components arepolyethylene terephthalate lacquer, alpha tocopherol, poly-(butylmethacrylate, methylmethacrylate), acrylic copolymer, silicone oil, dimethicone, polyester film coated with fluoropolymer.
Appearance of the product and contents of the pack
Thin transdermal patch composed of three layers. The outer layer is beige and marked with:
-“Exelon”,“4.6mg/24h”and“AMCX”.
-“Exelon”,“9.5mg/24h”and“BHDI”.
-“Exelon”,“13.3mg/24h”and“CNFU”.
Each carton contains a transdermal patch.
Exelon 4.6mg/24h transdermal patch and Exelon 9.5mg/24h transdermal patch are available in cartons containing 7, 30 or 42sheets and multiple cartons containing 60, 84 or 90sheets.
Exelon 13.3mg/24htransdermal patches are available in cartons containing 7 or 30sheets and multiple cartons containing 60 or 90sheets.
Only some pack sizes may be marketed.
Marketing Authorisation Holder
Novartis Europharm Limited
Vista Building
Elm Park, Merrion Road
Dublin 4
Ireland
Manufacturer
Novartis Pharma GmbH
Roonstraße 25
D-90429Nürnberg
Germany
For further information about this medicinal product, please contact the local representative of the marketing authorisation holder:
België/Belgique/Belgien Novartis Pharma N.V. Tél/Tel: +32 2 246 16 11 | Lietuva SIA „Novartis Baltics“ Lietuvos filialas Tel: +370 5 269 16 50 |
???????? Novartis Bulgaria EOOD ???:+359 2 489 98 28 | Luxembourg/Luxemburg Novartis Pharma N.V. Tél/Tel: +32 2 246 16 11 |
Ceská republika Novartis s.r.o. Tel: +420 225 775 111 | Magyarország Novartis Hungária Kft. Tel.: +36 1 457 65 00 |
Danmark Novartis Healthcare A/S Tlf: +45 39 16 84 00 | Malta Novartis Pharma Services Inc. Tel: +3562122 2872 |
Deutschland Novartis Pharma GmbH Tel: +49 911 273 0 | Nederland Novartis Pharma B.V. Tel: +31 26 37 82 111 |
Eesti SIA Novartis Baltics Eesti filiaal Tel: +37266 30 810 | Norge Novartis Norge AS Tlf: +47 23 05 20 00 |
Ελλ?δα Novartis (Hellas) A.E.B.E. Τηλ: +30 210 281 17 12 | Österreich Novartis Pharma GmbH Tel: +43 1 86 6570 |
España Novartis Farmacéutica, S.A. Tel: +34 93 306 42 00 | Polska Novartis Poland Sp. z o.o. Tel.: +48 22 375 4888 |
France Novartis Pharma S.A.S. Tél: +33 1 55 47 66 00 | Portugal Novartis Farma - Produtos Farmacêuticos, S.A. Tel: +351 21 000 8600 |
Hrvatska Novartis Hrvatska d.o.o. Tel. +385 1 6274 220 | România Novartis Pharma Services Romania SRL Tel: +40 21 31299 01 |
Ireland Novartis Ireland Limited Tel: +353 1 260 12 55 | Slovenija Novartis Pharma Services Inc. Tel: +386 1 300 75 50 |
Ísland Vistor hf. Sími: +354 535 7000 | Slovenská republika Novartis Slovakia s.r.o. Tel: +421 2 5542 5439 |
Italia Novartis Farma S.p.A. Tel: +39 02 96 54 1 | Suomi/Finland Novartis Finland Oy Puh/Tel: +358(0)10 6133 200 |
Κ?προς Novartis Pharma Services Inc. Τηλ: +357 22 690 690 | Sverige Novartis Sverige AB Tel: +46 8 732 32 00 |
Latvija SIA “Novartis Baltics” Tel: +371 67 887 070 | United Kingdom Novartis Pharmaceuticals UK Ltd. Tel: +44 1276 698370 |
Last update of the summary of product characteristics:
Other sources of information
The detailed information on this medicinal product is available on the website of the European Medicines Agency:http://www.ema.europa.eu
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.